PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Genes & Development

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/gad.1972310PMID 20889717PMCID PMC2947772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• The EGFRvIII variant in glioblastoma multiforme.

  2009cited by this paper
• Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis

  2009cited by this paper
• Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma

  2009cited by this paper
• Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations

  2009cited by this paper
• Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas

  2009cited by this paper
• Comprehensive genomic characterization defines human glioblastoma genes and core pathways

  2008cited by this paper
• Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

  2008cited by this paper
• Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.

  2008cited by this paper
• The impact of translocations and gene fusions on cancer causation

  2007influential reference
• Genetic pathways to primary and secondary glioblastoma.

  2007cited by this paper
• Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies

  2007cited by this paper
• Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

  2006cited by this paper
• Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells.

  2006cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma

  2006cited by this paper
• Phase I/II Study of Imatinib Mesylate for Recurrent Malignant Gliomas: North American Brain Tumor Consortium Study 99-08

  2006cited by this paper
• Evidence of recurrent gene fusions in common epithelial tumors.

  2006cited by this paper
• Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas.

  2005cited by this paper
• Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

  2005cited by this paper
• Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

  2005cited by this paper
• Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer

  2004cited by this paper
• Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

  2003cited by this paper
• A human brain tumor-derived PDGFR-alpha deletion mutant is transforming.

  2003cited by this paper
• A human brain tumor-derived PDGFR-α deletion mutant is transforming

  2003influential reference
• Receptor Heterodimerization: Essential Mechanism for Platelet-Derived Growth Factor-Induced Epidermal Growth Factor Receptor Transactivation

  2001influential reference
• Kinase Insert Domain Receptor (KDR) Extracellular Immunoglobulin-like Domains 4–7 Contain Structural Features That Block Receptor Dimerization and Vascular Endothelial Growth Factor-induced Signaling*

  2001cited by this paper
• Oncogenic kinase signalling

  2001cited by this paper
• PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

  2001influential reference
• PTK 787 / ZK 222584 , a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases , Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration

  2000cited by this paper
• PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

  2000cited by this paper
• Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.

  1998cited by this paper
• A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.

  1998cited by this paper
• Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).

  1997influential reference
• Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

  1996cited by this paper
• A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a heterodimeric receptor complex.

  1994cited by this paper
• Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin.

  1992cited by this paper
• Structural alterations of the epidermal growth factor receptor gene in human gliomas.

  1992cited by this paper
• Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo.

  1991cited by this paper
• Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.

  1990cited by this paper

• Advancements in Drug Delivery Systems in Glioblastoma Therapy

  2026cites this paper
• Dysregulation of post-translational modifications in glioma: advances in pathological mechanisms and clinical targeting strategies

  2026cites this paper
• Disrupting PDGFRA-driven immune evasion in glioma: vaccine-based strategies on the horizon

  2026cites this paper
• Mapping kinase-dependent tumor immune adaptation with multiplexed single-cell CRISPR screens

  2026cites this paper
• Histone demethylase KDM6B inhibitor GSK-J4 sensitizes glioma cells to tyrosine kinase inhibitor anlotinib in vitro by reducing PDGFRA expression

  2026cites this paper
• Chromothripsis and ecDNA initiated by N4BP2 nuclease fragmentation of cytoplasm-exposed chromosomes.

  2025cites this paper
• Chromosomal gain and mutations of platelet-derived growth factor receptor-α gene in canine high-grade oligodendroglioma

  2025cites this paper
• Empowering rapid diagnosis and treatment of glioblastoma with biofunctionalized carbon quantum dots: a review

  2025cites this paper
• PDGFRA in paediatric high-grade glioma – target or distraction?

  2025influential citation
• Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies

  2025cites this paper
• MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma.

  2025cites this paper
• Molecular Biomarkers of Glioma

  2025cites this paper
• Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

  2025cites this paper
• The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma

  2024cites this paper
• Therapeutic advances of targeting receptor tyrosine kinases in cancer

  2024cites this paper
• Involvement of PDGFR‐integrin interactions in the regulation of anoikis resistance in glioblastoma progression

  2024cites this paper
• Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials

  2024cites this paper
• Genomic landscape of glioblastoma without IDH somatic mutation in 42 cases: a comprehensive analysis using RNA sequencing data

  2024cites this paper
• The relationships of platelet-derived growth factor, microvascular proliferation, and tumor cell proliferation in canine high-grade oligodendrogliomas: Immunohistochemistry of 45 tumors and an AFOB-01 xenograft mouse model

  2024cites this paper
• PDGFRA K385 mutants in myxoid glioneuronal tumors promote receptor dimerization and oncogenic signaling

  2024cites this paper
• Fusion of Platelet Derived Growth Factor Receptor Alpha (PDGFRA) With Ubiquitin Specific Peptidase 8 (USP8) in a Calcified Chondroid Mesenchymal Neoplasm Harboring t(4;15)(q12;q21) as a Sole Aberration

  2024cites this paper
• The Effect of Therapy Regimen on Antitumor Efficacy of the Nanosomal Doxorubicin against Rat Glioblastoma 101.8

  2024cites this paper
• From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress

  2023cites this paper
• Expanding the spectrum of tyrosine kinase fusions in calcified chondroid mesenchymal neoplasms: Identification of a novel PDGFRA::USP8 gene fusion

  2023cites this paper
• Oncogenic Long Non-coding RNA LINC02283 Enhances PDGF Receptor A mediated Signaling and Drives Glioblastoma Tumorigenesis.

  2023cites this paper
• Mutaciones en los genes PDGFRA, KIT y KDR en pacientes con glioblastoma se relacionan con un peor desenlace

  2023cites this paper
• Inflammatory fibroid polyp of the renal pelvis: first report at an extra-gastrointestinal site with molecular confirmation

  2023cites this paper
• EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection

  2023cites this paper
• Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic Teratoma.

  2023cites this paper
• Metanephric stromal tumor in an adult with PDGFRA mutation: a case report

  2023cites this paper
• Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target

  2023cites this paper
• An oncogenic splice variant of PDGFRα in adult glioblastoma as a therapeutic target for selective CDK4/6 inhibitors

  2022cites this paper
• Germline MUTYH mutations and high‐grade gliomas: Novel evidence for a potential association

  2022cites this paper
• A Comprehensive Clinical Review of Adult-Type Diffuse Glioma Incorporating the 2021 World Health Organization Classification

  2022cites this paper
• Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma

  2022cites this paper
• Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single‐Cell Resolution using a Microfluidic Tumor Microenvironment Model

  2022cites this paper
• Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors

  2022cites this paper
• Platelet-derived growth factor signalling in neurovascular function and disease.

  2022cites this paper
• A Targeted Next-Generation Sequencing Panel to Genotype Gliomas

  2022cites this paper
• Signaling by PDGFR in disease

  2022cites this paper
• Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG

  2021cites this paper
• Tyrosine Kinase Inhibitors in Adult Glioblastoma: An (Un)Closed Chapter?

  2021cites this paper
• Integrative multi‐omic analysis reveals neurodevelopmental gene dysregulation in CIC ‐knockout and IDH1 ‐mutant cells

  2021cites this paper
• High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?

  2021cites this paper
• Genomic Heterogeneity of Aggressive Pediatric and Adult Diffuse Astrocytomas

  2021cites this paper
• The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin

  2021cites this paper
• Understanding signal transduction pathways to overcome targeted therapy resistance in glioblastoma

  2021cites this paper
• Fusion Genes Altered in Adult Malignant Gliomas

  2021cites this paper
• Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment

  2021cites this paper
• Molecular Alterations and Their Correlation With the Survival of Glioblastoma Patients With Corpus Callosum Involvement

  2021cites this paper
• PDGF receptor mutations in human diseases

  2021cites this paper
• Kinomics platform using GBM tissue identifies BTK as being associated with higher patient survival

  2021cites this paper
• Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

  2021cites this paper
• Omeprazole Inhibits Glioblastoma Cell Invasion and Tumor Growth

  2020cites this paper
• Tumor edge architecture in glioblastoma is constructed by intercellular signals 1 from vascular endothelial cells 2 3

  2020cites this paper
• Glioblastomas harboring gene fusions detected by next-generation sequencing

  2020cites this paper
• Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma

  2020cites this paper
• Endothelial Cells stimulate proliferation of CD140a sorted human Glial Progenitor Cells and their specification towards astrocytic lineage

  2020cites this paper
• Clinical and biologic roles of PDGFRA in papillary thyroid cancer: a study based on immunohistochemical and in vitro analyses.

  2020cites this paper
• PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas

  2020cites this paper
• KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitors

  2020cites this paper
• INTRATUMORAL HETEROGENEITY IN GLIOBLASTOMA: SUBTYPE TRANSITION AND CELL-TO-CELL COMMUNICATION

  2020cites this paper
• Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells

  2020cites this paper
• Endothelial-secreted Endocan protein acts as a PDGFR alpha ligand and regulates vascularity, radioresistance, and regional phenotype in glioblastoma

  2020cites this paper
• Dysregulated PDGFR alpha expression and novel somatic mutations in colorectal cancer: association to RAS wild type status and tumor size

  2020cites this paper
• Heparan Sulfate Synthesized by Ext1 Regulates Receptor Tyrosine Kinase Signaling and Promotes Resistance to EGFR Inhibitors in GBM

  2020cites this paper
• Myxoid glioneuronal tumor, PDGFRA p.K385‐mutant: clinical, radiologic, and histopathologic features

  2020cites this paper
• Receptor Tyrosine Kinases: Principles and Functions in Glioma Invasion.

  2020cites this paper
• The Role of SVZ Stem Cells in Glioblastoma

  2019cites this paper
• Glioblastomas derived from genetically modified pluripotent stem cells recapitulate pathobiology

  2019cites this paper
• Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development

  2019cites this paper
• Expression of Alpha-type Platelet-derived Growth Factor Receptor–influenced Genes Predicts Clinical Outcome in Glioma

  2019cites this paper
• The Drosophila Model in Cancer

  2019cites this paper
• Drosophila melanogaster as a Model System for Human Glioblastomas.

  2019cites this paper
• Signal transduction pathways and resistance to targeted therapies in glioma.

  2019cites this paper
• Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes

  2019cites this paper
• Mining Potential MicroRNA Biomarkers related to IQGAPs of Thyroid Carcinoma through in silico process.

  2019cites this paper
• The potential diagnostic and prognostic role of extracellular vesicles in glioma: current status and future perspectives

  2019cites this paper
• The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma

  2018cites this paper
• Balance of Forces: Regulation of protein tyrosine phosphorylation by PTPs and RTKs in glioma

  2018cites this paper
• An RNA Aptamer Targeting the Receptor Tyrosine Kinase PDGFRα Induces Anti-tumor Effects through STAT3 and p53 in Glioblastoma

  2018cites this paper
• The RTK Interactome: Overview and Perspective on RTK Heterointeractions.

  2018cites this paper
• CRISPR‐engineered genome editing for the next generation neurological disease modeling

  2018cites this paper
• Lgl1 controls NG2 endocytic pathway to regulate oligodendrocyte differentiation and asymmetric cell division and gliomagenesis

  2018cites this paper
• Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome

  2018cites this paper
• Emerging Gene Fusion Drivers in Primary and Metastatic Central Nervous System Malignancies: A Review of Available Evidence for Systemic Targeted Therapies.

  2018cites this paper
• Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA , PDGFRB , FGFR1, or t(8;9)(p22;p24.1); PCM1-JAK2

  2018cites this paper
• Spontaneous development of intratumoral heterogeneity in a transposon‐induced mouse model of glioma

  2018cites this paper
• Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas

  2018cites this paper
• Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors

  2018cites this paper
• Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis

  2018cites this paper
• Activation of Rac 1 by Src-dependent phosphorylation of Dock 180 Y 1811 mediates PDGFR a-stimulated glioma tumorigenesis in mice and humans

  2018cites this paper
• Loss of PRMT5 promotes PDGFRα degradation during oligodendrocyte differentiation and myelination

  2018cites this paper
• Biomarkers and therapeutic advances in glioblastoma multiforme

  2018cites this paper
• Pediatric High Grade Glioma

  2017cites this paper
• Clinical Significance of Genes in the NeoTYPE Brain Tumor Profile

  2017cites this paper
• Targeting cellular pathways in glioblastoma multiforme

  2017cites this paper
• Advances in Biology and Treatment of Glioblastoma

  2017cites this paper
• The Role of PDGFs and PDGFRs in Colorectal Cancer

  2017cites this paper
• Molecular mechanisms and therapeutic targets in pediatric brain tumors

  2017cites this paper